10x Genomics, Inc.

Historical 13F Holders

Symbol
TXG
CUSIP
88025U109
All holders as of
Q3 2026
Type
Equity
Class
CL A COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 88025U109 since 12/18/2024, largest first.

Filer % of Class Filed
FMR LLC 13G/A
15.6% 3/6/2026
Event 2/27/2026
Price T Rowe Associates Inc /MD/ 13G 11.7% 9/8/2026
Event 8/31/2026
BlackRock, Inc. 13G/A 7.6% 7/16/2025
Event 6/30/2025
Vanguard Portfolio Management LLC 13G 5.9% 4/28/2026
Event 3/31/2026
Vanguard Capital Management LLC 13G 5.2% 4/29/2026
Event 3/31/2026
ARK Investment Management LLC 13G/A
5.2% 10/7/2026
Event 9/30/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (4)
Sumitomo Mitsui Trust Group, Inc. 13G/A
4.7% 10/27/2025
Event 9/30/2025
Amova Asset Management Americas, Inc. 13G/A 4.7% 11/13/2025
Event 9/30/2025
Millennium Management LLC 13G/A
2.7% 8/12/2025
Event 6/30/2025
Vanguard Group Inc 13G/A 0% 3/25/2026
Event 3/13/2026

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 379 90.2 M $8.14B
2026 Q2 397 128 M $4.92B
2026 Q1 337 125 M $2.66B
2025 Q4 328 124 M $2.02B
2025 Q3 324 123 M $1.43B
2025 Q2 302 123 M $1.42B
2025 Q1 278 114 M $996M
2024 Q4 277 105 M $1.50B
2024 Q3 269 104 M $2.36B
2024 Q2 263 105 M $2.05B
2024 Q1 293 103 M $3.88B
2023 Q4 278 96.0 M $5.37B
2023 Q3 259 90.9 M $3.75B
2023 Q2 278 89.1 M $4.98B
2023 Q1 262 90.2 M $5.03B
2022 Q4 271 87.6 M $3.19B
2022 Q3 235 86.1 M $2.45B
2022 Q2 255 86.1 M $3.91B
2022 Q1 320 82.8 M $6.30B
2021 Q4 369 80.0 M $11.9B
2021 Q3 334 78.8 M $11.5B
2021 Q2 347 77.9 M $15.3B
2021 Q1 329 70.6 M $12.8B
2020 Q4 311 66.2 M $9.39B
2020 Q3 224 69.1 M $8.55B
2020 Q2 151 61.0 M $5.45B
2020 Q1 108 38.9 M $2.43B
2019 Q4 87 30.8 M $2.35B
2019 Q3 93 22.3 M $1.13B